Background: Although cerebral lesions 3 mm or larger on imaging are associated with incident stroke, lesions smaller than 3 mm are typically ignored.
S ubclinical brain infarctions (SBIs) are usually defined as lesions larger than 3 mm on brain imaging (1, 2) in persons with no history of clinical stroke. Both SBIs and white matter hyperintensities (WMHs) have been associated with increased risk for stroke and death, primarily in older persons (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Brain structural abnormalities may be objective markers of stroke risk, yet lesions smaller than 3 mm are typically ignored in clinical and research settings because of potential misclassification of presumed nonvascular lesions (such as Virchow-Robin spaces) as vascular lesions and a lack of data on associations with outcomes. However, even very small lesions may be mediated through vascular processes, such as infarctions, leukoaraiosis, and endothelial dysfunction (15) (16) (17) (18) . The STRIVE (Standards for Reporting Vascular Changes on Neuroimaging) consortium recently included small lesions, including potential perivascular spaces, as a possible form of cerebral small vessel disease (18) . The relationship between lesions smaller than 3 mm and important clinical outcomes is unknown. If even very small lesions (<3 mm) are associated with stroke and mortality, they may enable early identification of at-risk persons in whom targeted preventive measures may be warranted.
Members of ethnic minority groups, including nonHispanic black persons, are more likely than white persons to have strokes, strokes at earlier ages, and strokerelated disability and death (19, 20) . Yet, most studies of brain structural abnormalities and stroke risk have been in older and primarily white populations (5, 6, 10, 13, 14, 21) . Increased stroke risk associated with brain vascular lesions has been observed in the younger Framingham Offspring cohort (6) , as have increased stroke and mortality in a middle-aged to older Japanese population (4) , but studies are limited in middle-aged persons and minority groups, including black persons. Identifying early markers of at-risk persons could significantly affect the public health burden of cerebrovascular disease in all ethnic groups, given associations with cognitive decline and dementia, gait impairment, and stroke (13, (22) (23) (24) (25) (26) .
The purpose of this study was to examine the associations of incident stroke, stroke-related mortality, and all-cause mortality with the presence of lesions smaller than 3 mm, lesions 3 mm or larger, lesions of both sizes, and WMHs in a middle-aged biracial population.
METHODS

Population
The ARIC (Atherosclerosis Risk in Communities) study cohort has been described previously (27) . Participants aged 55 years or older from Forsyth County, North Carolina, and Jackson, Mississippi, were invited to undergo brain magnetic resonance imaging (MRI) at ARIC visit 3 (1993 to 1995; n = 2892). Of these, 103 were ineligible for safety reasons, 654 declined, 122 did not initially decline but did not undergo MRI, 73
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attempted but did not complete MRI, and 6 completed MRI forms but had no data (Appendix Figure 1 , available at www.annals.org). Participants who had MRI were older (62 vs. 58 years) but were otherwise similar to those who did not have MRI (Appendix Table 1 , available at www.annals.org). We obtained MRI data on 1934 participants and excluded 46 with prevalent strokes and 4 who reported nonwhite, nonblack ethnicity, leaving 1884 for this analysis. Institutional review boards approved study protocols, and all participants provided informed consent.
Brain Imaging
Protocols for brain MRI have been described in detail and were identical to those used in the CHS (Cardiovascular Health Study) (28, 29) . Briefly, 5-mm contiguous axial T1-, T2-, and proton density-weighted images of the whole brain were obtained using 1.5-Tesla scanners. Subclinical brain infarctions were defined by shape, absence of mass effect, and hyperintensity to gray matter on proton density-weighted and T2-weighted images, in contrast to perivascular spaces, which show intensity similar to that of cerebrospinal fluid as well as typical locations and morphology (30) . Subclinical brain infarctions within deep cerebral white matter were also required to be hypointense on T1-weighted images. The maximal right-to-left and anterior-to-posterior lesion dimensions were recorded with an electronic cursor. The superior-to-inferior dimension was reported as the number of 5-mm axial sections on which the lesion appeared. Lesions smaller than 3 mm on right-to-left or anterior-to-posterior measurements were recorded as "less than 3 mm" (28, 31) . Images were double-read independently by 2 neuroradiologists, and discrepant cases were adjudicated by consensus among 3 or more readers.
We included cortical and noncortical lesions. Lacunes were defined as 3-to 20-mm noncortical lesions in the basal ganglia, brainstem, thalamus, internal capsule, or cerebral white matter. Nonlacunar lesions were defined as 3-to 20-mm lesions outside these areas or lesions larger than 20 mm in any area on right-to-left or anterior-to-posterior measurements. The number of lesions smaller than 3 mm was recorded as 0, 1 to 2, or more than 2, and the number of lesions 3 mm or larger was recorded as 0, 1, or 2 or more (up to 5) (28, 31) .
Periventricular and subcortical WMHs were graded on a scale of 0 (no white matter signal abnormalities) to 9 (extensive confluent white matter involvement), based on pattern matching to a set of reference standards (29, 32) .
Incident Stroke and Mortality Ascertainment and Criteria
Adjudicated nonfatal and fatal clinical strokes requiring hospitalization were identified through yearly telephone interviews and surveillance methods that also included hospital record reviews and medical chart abstraction (33). Deaths were identified through contacts with next of kin, hospital records, state death records, and the National Death Index. Stroke-related deaths were adjudicated by expert stroke reviewers. Follow-up was complete through 2010.
Stroke was defined according to the National Survey of Stroke criteria and required evidence of sudden or rapid onset of neurologic symptoms that persisted for more than 24 hours or led to death with no other apparent cause, such as trauma, tumor, infection, or anticoagulation (7, 33, 34) . Of patients hospitalized for stroke, 99% had diagnostic computed tomography (CT) or MRI (7) . Ischemic stroke was defined as symptoms plus acute infarction or absence of hemorrhage on imaging. Hemorrhagic stroke met one of the following criteria: CT or MRI with intraparenchymal hematoma; demonstration at autopsy or surgery; or at least 1 major or 2 minor neurologic deficits, bloody spinal fluid on lumbar puncture, no CT or MRI with or without cerebral angiography demonstrating an avascular mass effect, and no evidence of aneurysm or arteriovenous malformation (7, 21, 33) .
Covariates
All covariates were measured at ARIC visit 3 when the MRI was conducted. Body mass index was calculated in kilograms per square meter. Hypertension was defined as systolic blood pressure of at least 140 mm Hg, diastolic blood pressure of at least 90 mm Hg, or use of antihypertensive medication in the previous 2 weeks. Diabetes mellitus was defined as a fasting blood glucose level of at least 7 mmol/L (126 mg/dL), a nonfasting blood glucose level greater than 11.1 mmol/L (200 mg/dL), antidiabetic medication use in the previous 2 weeks, or a physician diagnosis of diabetes. Standardized questionnaires were used to ascertain medical history, smoking, and alcohol consumption. Smoking and alcohol use were categorized as never, former, or current. Educational attainment was catego-
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Context Subclinical brain infarctions are typically defined as lesions 3 mm or larger on imaging in patients without a history of stroke. The clinical significance of lesions smaller than 3 mm is unknown.
Contribution
This prospective longitudinal study involved 2892 adults living in 2 U.S. communities who had brain magnetic resonance imaging (MRI) at baseline. Hospitalizations for nonfatal and fatal strokes were ascertained yearly during follow-up (average, 14.5 years).
Caution
One quarter of patients declined to have brain MRI.
Implication
Very small brain lesions were associated with an increased risk for stroke and death. The risks were greater if lesions 3 mm or larger were also present. 
Statistical Analysis
We examined associations between participant characteristics and lesion size (no lesions, <3 mm only, ≥3 mm only, and both sizes) by using Fisher exact tests, Kruskal-Wallis tests, and multinomial regression to estimate relative risk ratios (RRRs).
Cumulative incidence curves show incidence of stroke and stroke-related mortality over time by lesion type and WMHs (standardized curves are provided in Appendix Figure 2 , available at www.annals.org). Cox proportional hazards models were used to estimate hazard ratios (HRs) for associations of MRI predictors with adjudicated event outcomes (incident stroke, stroke subtype, all-cause mortality, and stroke-related mortality). We used a single model to examine the associations of presence of no lesions versus very small lesions only (<3 mm) versus larger lesions only (≥3 mm) versus lesions of both sizes. We then examined the presence and number of very small lesions (doseresponse effects) in separate models (for example, associations of presence of very small lesions regardless of presence of larger ones) to preserve cell sizes when examining numbers of lesions. Presence of larger lesions, lacunar and nonlacunar infarctions, and number of lacunar infarctions were also examined in separate models to preserve cell sizes. White matter hyperintensities were examined as an ordinal (grade 0 to 9) and a categorical (grade <3 vs. ≥3) variable (14, 29) .
Models were adjusted for covariates chosen a priori, including age, sex, a 3-level race-center variable (black-Forsyth, black-Jackson, and white-Forsyth), education level, body mass index, smoking, alcohol use, diabetes, systolic and diastolic blood pressures, antihypertensive medication use, heart disease, statin use, 342 (18) 277 (17) 7 (14) 44 (24) 13 (38) 0.003 Diabetes, n (%)
326 (17) 264 (17) 12 (24) 39 (22) 11 (32) 802 (43) 636 (40) 27 (54) 110 (59) 28 (80) <0.001 Heart disease, n (%)
103 (6) 82 (5) 3 (6) 14 (8) 3 (9) 
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high-and low-density lipoprotein cholesterol levels, and triglyceride level. Models that were adjusted for only the first 3, 4, and 7 covariates provided quantitatively similar results with the same conclusions, as did additional adjustments for aspirin use; unadjusted models provided the same conclusions with larger effect sizes. Proportional hazards assumptions did not seem to be violated via diagnostic log-log survival plots and Schoenfeld residual tests (P = 0.69 for stroke). Effect modifications by sex, race, and age were unsupported. We used Stata, version 13 (StataCorp), for all analyses.
Role of the Funding Source
The funding sources had no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
RESULTS
Over an average follow-up of 14.5 years, there were 157 clinical strokes, 50 stroke-related deaths, and 576 all-cause deaths. Among patients without stroke, 90% had more than 10 years of follow-up. Table 1 shows the population characteristics at visit 3, stratified by presence and size of lesion. The median age was 63 years (range, 50 to 73 years), 50% of participants were black, and 60% were women. Most participants (64%) were younger than 65 years at the MRI 
157 (9) 23 (7) 1410 (37) 37 (3) 121 ( Most strokes (89%) were ischemic, with similar estimates reported for any stroke and ischemic stroke. Cumulative incidence curves associated with lesion size are shown in the Figure (top Table 2) . Stroke-related deaths were too rare to estimate relationships. HR = hazard ratio; WMH = white matter hyperintensity. * HRs and 95% CIs were estimated from Cox proportional hazards models adjusted for age, sex, race-center, education level, body mass index, smoking status, alcohol use, diabetes, systolic and diastolic blood pressures, antihypertensive medication use, heart disease, high-and low-density lipoprotein cholesterol and triglyceride levels, and statin use. All estimates except those for WMH grades are based on comparisons with the reference category of no lesions (n = 1611). † Too few data to support estimates. ‡ 3-to 20-mm lesions not located in the basal ganglia, brainstem, thalamus, internal capsule, or cerebral white matter or those larger than 20 mm in any area on right-to-left or anterior-to-posterior measurements. § 3-to 20-mm lesions located in the basal ganglia, brainstem, thalamus, internal capsule, or cerebral white matter (including those in patients who may also have had small infarctions). Includes 31 participants who also had a very small lesion (<3 mm).
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Presence and Number of Lesions 3 mm or Larger
Presence of any lesion 3 mm or larger was associated with an increased risk for incident stroke ( 
Risk Factors for Lesion Occurrence
The primary characteristic associated with presence of very small lesions only (<3 mm) was hypertension (RRR, 2.17 [CI, 1.14 to 4.13]) ( Table 3) . Presence of larger lesions only (≥3 mm) was associated with hypertension (RRR, 1.71 [CI, 1.20 to 2.43]) as well as older age, black race, and current smoking status. Consistent with established risk factors for cerebrovascular disease (10, 13, 22) , older age, black race, smoking, and hypertension (RRR, 6.01 [CI, 2.01 to 17.99]) were associated with presence of lesions of both sizes, whereas higher education level was protective. Interaction terms between lesions or WMHs and sex, race, or age in separate models did not support differential relationships between MRI abnormalities and stroke or mortality outcomes, although sample sizes were limited for investigations of effect modifications.
DISCUSSION
Our study demonstrates that among asymptomatic middle-aged to older persons with no history of clinical stroke, even very small lesions in the brain were associated with risks for stroke and death-similar to lesions within typical clinically defined size thresholds (3 to 20 Although clinicians and researchers tend to dismiss very small cerebral lesions, our findings provide evidence that this practice could warrant reconsideration. Whether lesions of this size represent vascular pathology or dilated perivascular spaces known as VirchowRobin spaces is unclear (30) . However, even perivascular spaces are increasingly recognized as potentially pathologic. Lesions of presumed vascular origin and perivascular spaces share similar risk profiles, and perivascular spaces are associated with cerebral small vessel disease severity (15) (16) (17) , stroke and cognitive decline (35) , WMHs (36, 37) , and symptomatic lacunar infarctions (16, 36) , all of which support a vascular pathology. In this study, expert neuroradiologists used a standard protocol and were aware of distinctions between infarctions and perivascular spaces (for example, location, shape, and intensity). Although we are highly confident in our classification of perivascular spaces versus silent infarctions, we acknowledge that the distinction is more difficult for infarctions smaller than 3 mm because signal intensity is more subject to partial voluming (the lesion is small relative to the slice or pixel volume) and the morphology is more difficult to characterize. However, perivascular spaces are now largely considered a form of vascular disease, potentially due to endothelial dysfunction (18) . Regardless of the cause of the lesions, our study shows that even very small lesions are associated with increased risk for stroke and death, adding to a growing corpus of literature supporting associations between very small lesions and cardiovascular risk factors (31) ; clinical disease, including atrial fibrillation (38) ; and, now, stroke and mortality.
Smaller (typically defined as 7 mm or smaller) and larger (typically 5 to 20 mm) cerebrovascular lacunar lesions are believed to differ pathogenically and clinically; the smaller ones develop from lipohyalinosis and, potentially, endothelial dysfunction (18) , whereas the larger ones are more likely to be symptomatic and due to microatheromatous disease (1). Our robust associations between lesions smaller than 3 mm and stroke and stroke-related mortality support the hypothesis that very small lesions are pathologic and clinically important. We extend previous work in the ARIC cohort that identified diabetes and hemoglobin A 1c levels as risk factors for lesions smaller than 7 mm, whereas lesions larger than 7 mm were associated with lowdensity lipoprotein cholesterol levels (31), consistent with Fisher's hypothesis (1) and previous studies on risk factors for silent lesions in the brain (2, 21, 22, 32, 39) . Our study extends these findings by examining lesions smaller than 3 mm separately from those as large as 7 mm. Hypertension showed the most robust association between a risk factor and lesions smaller than 3 mm, followed by age and black race; all are well-known risk factors for stroke and cardiovascular disease (2, 22, 29) . The associations with cardiovascular risk factors further support the hypothesis that these lesions represent early microvascular disease.
Associations with stroke seem stronger for lesions smaller than 3 mm than for larger ones. This finding has several potential explanations. First, there were few events, with overlapping CIs for lesions smaller than 3 mm and those 3 mm or larger, so the true association could also be smaller than or similar to that of lesions 3 mm or larger. Larger lesions could have led to strokes, resulting in death, dropout, or exclusion from the analysis due to prevalent stroke. However, persons with strokes at the baseline visit were excluded, and death or loss to follow-up due to stroke seem unlikely because follow-up was high.
Our data support a dose-response mechanism, which adds support for causal associations; risks for stroke and death were increased with lesions of either Future studies are needed to examine the effect of preventive treatment in asymptomatic persons, including those with even the smallest abnormalities. Strengths of this study include a middle-aged cohort at baseline with a large representation of black persons, standardized measures of MRI lesions, and validated ascertainment of incident stroke and stroke subtypes. Limitations include the infrequency of events, particularly hemorrhagic stroke (n = 15) and strokerelated death (n = 50). Despite the small samples, strong associations were observed. Studies with larger numbers of stroke events are needed to provide more stable and precise estimates of the relative risks associated with very small lesions. Use of 1.5-Tesla MRI and potential misclassification of lesions smaller than 3 mm due to lower pixel resolution may be considered limitations given that higher-resolution imaging is now available. We expect most misclassification of lesions smaller than 3 mm to result in noninfarctions being labeled as infarctions and to bias results to null findings. Thus, we believe our findings are conservative. Newer high-definition imaging might improve classification of lesions smaller than 3 mm and should be examined in future studies to confirm our results. Although recent recommendations consider lesions of presumed vascular origin to measure 3 to 15 mm (30), we used an established definition of 3 to 20 mm at the time of this study. However, our study focused on risk associated with lesions smaller than 3 mm, and the definition we used is consistent with previous studies (2, 12, 29, 41) .
In conclusion, we found that the presence of lesions smaller than 3 mm only, lesions 3 mm or larger only, and WMHs may be associated with heightened risk for incident stroke and death in middle-aged and older black and white adults. The simultaneous presentation of lesions of both sizes may represent a particularly marked increase in risk. Larger studies are needed to confirm these findings, provide more precise estimates, and investigate physiologic pathways. 
